ArticleActa pharmacologica Sinica2024

Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages.

Ting-Ting Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.